<DOC>
	<DOCNO>NCT00822055</DOCNO>
	<brief_summary>This study compare efficacy tolerability/comfort brimonidine/timolol dorzolamide/timolol patient open-angle glaucoma ocular hypertension . In investigator mask randomisation process , subject allocate receive either brimonidine/timolol dorzolamide/timolol fixed-combination monotherapy adjunctive prostaglandin analogue period 12 week . After screen , patient return baseline , Month 1 Month 3 ophthalmic evaluation .</brief_summary>
	<brief_title>Comparison Fixed Combinations Brimonidine/Timolol Dorzolamide/Timolol Subjects With Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>Male female 18 year Female subject childbearing potential must negative pregnancy test practice contraception Subjects must confirm diagnosis primary openangle glaucoma ocular hypertension eye Subjects insufficiently responsive IOP reduce monotherapy use either study medication deem appropriate Subjects able complete questionnaire provide inform consent Female subject pregnant , plan become pregnant study period , breast feeding practice reliable method birth control Subjects wherein study drug contraindicate Subjects intraocular surgery 6 month ( 3 month laser ) Subjects known side effects/allergy sensitivity component study treatment Subjects uncontrolled systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>